Cargando…
Data on the in vitro and in vivo anti-tumor effects of itraconazole, paclitaxel, and the two in combination in HT-29 and YM-1 cancer cell line and HT-29 colon cancer xenograft models
Colon cancer is one of the fatal cancers in the world that metastatic potential and resistance to chemotherapy drugs are outstanding causes of cancer-induced mortality [1], [2], [3], [4]. We have investigated in vitro and in vivo anti-cancer effect of itraconazole and paclitaxel alone and their anti...
Autores principales: | Ghadi, Mahdi, Hosseinimehr, Seyed Jalal, Talebpour Amiri, Fereshteh, Mardanshahi, Alireza, Noaparast, Zohreh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903292/ https://www.ncbi.nlm.nih.gov/pubmed/33665257 http://dx.doi.org/10.1016/j.dib.2021.106862 |
Ejemplares similares
-
Radiotherapy Enhancement with Electroporation in Human Intestinal Colon Cancer HT-29 Cells
por: Yadollahpour, Ali, et al.
Publicado: (2018) -
(99m)Tc-Glucarate for assessment of paclitaxel therapy in human ovarian cancer in mice
por: Sadeghi, Hossein, et al.
Publicado: (2018) -
Molecular Targeting of Carbonic Anhydrase IX in Mice with Hypoxic HT29 Colorectal Tumor Xenografts
por: Carlin, Sean, et al.
Publicado: (2010) -
The Effect of Avidin on Viability and Proliferation of Colorectal Cancer Cells HT-29
por: Dewi, Syarifah, et al.
Publicado: (2022) -
Sorting of sphingolipids in the endocytic pathway of HT29 cells
Publicado: (1991)